Advertisement
Auxly Cannabis Group Inc.

Auxly Cannabis Group Inc. Fundamental Analysis

XLY.TOTSX
HealthcareDrug Manufacturers - Specialty & Generic
$0.19
$0.01(6.94%)
Canadian Market is Open · 10:53
Advertisement

Auxly Cannabis Group Inc. Fundamental Analysis

Auxly Cannabis Group Inc. (XLY.TO) shows moderate financial fundamentals with a PE ratio of 7.88, profit margin of 20.94%, and ROE of 19.79%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position16.04%
PEG Ratio0.17
Current Ratio2.23

Areas of Concern

No major concerns flagged.
We analyze XLY.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 77.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
77.2/100

We analyze XLY.TO's fundamental strength across five key dimensions:

Efficiency Score

Excellent

XLY.TO demonstrates superior asset utilization.

ROA > 10%
11.87%

Valuation Score

Excellent

XLY.TO trades at attractive valuation levels.

PE < 25
7.88
PEG Ratio < 2
0.17

Growth Score

Moderate

XLY.TO shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

XLY.TO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.30
Current Ratio > 1
2.23

Profitability Score

Excellent

XLY.TO achieves industry-leading margins.

ROE > 15%
19.79%
Net Margin ≥ 15%
20.94%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is XLY.TO Expensive or Cheap?

P/E Ratio

XLY.TO trades at 7.88 times earnings. This suggests potential undervaluation.

7.88

PEG Ratio

When adjusting for growth, XLY.TO's PEG of 0.17 indicates potential undervaluation.

0.17

Price to Book

The market values Auxly Cannabis Group Inc. at 1.42 times its book value. This may indicate undervaluation.

1.42

EV/EBITDA

Enterprise value stands at 5.27 times EBITDA. This is generally considered low.

5.27

How Well Does XLY.TO Make Money?

Net Profit Margin

For every $100 in sales, Auxly Cannabis Group Inc. keeps $20.94 as profit after all expenses.

20.94%

Operating Margin

Core operations generate 13.50 in profit for every $100 in revenue, before interest and taxes.

13.50%

ROE

Management delivers $19.79 in profit for every $100 of shareholder equity.

19.79%

ROA

Auxly Cannabis Group Inc. generates $11.87 in profit for every $100 in assets, demonstrating efficient asset deployment.

11.87%

Following the Money - Real Cash Generation

Operating Cash Flow

Auxly Cannabis Group Inc. produces operating cash flow of $37.42M, showing steady but balanced cash generation.

$37.42M

Free Cash Flow

Auxly Cannabis Group Inc. generates strong free cash flow of $34.02M, providing ample flexibility for dividends, buybacks, or growth.

$34.02M

FCF Per Share

Each share generates $0.02 in free cash annually.

$0.02

FCF Yield

XLY.TO converts 12.03% of its market value into free cash.

12.03%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

7.88

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.17

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.42

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.72

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.30

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.23

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.20

vs 25 benchmark

ROA

Return on assets percentage

0.12

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How XLY.TO Stacks Against Its Sector Peers

MetricXLY.TO ValueSector AveragePerformance
P/E Ratio7.8833.74 Better (Cheaper)
ROE19.79%404.00% Weak
Net Margin20.94%-40219.00% (disorted) Strong
Debt/Equity0.300.81 Strong (Low Leverage)
Current Ratio2.235.53 Strong Liquidity
ROA11.87%-281.00% (disorted) Strong

XLY.TO outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Auxly Cannabis Group Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ